I wonder where we are at with our so called cancer vaccine. Seems this was a slightly different approach to similar issue?? I'm no scientist but maybe this approach is different? And maybe more adaptable. Especially to solid tumors? It seems the Car-t method, while having impressive results , is still considered a last ditch effort after other multiple proven therapies have failed. Seems to have potentially serious side effects and risks. Not sure if our vaccine approach has better safety? I was thinking that if I understand the info our previous approach means we dont even have to harvest, engineer and re introduce patient's own t cells, but I'm probably wrong there. If that were the case though this would have massive cost benefits. I guess the antigens need to be specific to targetted cancer cells.
https://*********.com.au/phylogica-peptide-technology-development-cancer-vaccine/
Its a small world, page-18
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $676.5M | |||
| Open | High | Low | Value | Volume |
| 14.0¢ | 14.5¢ | 13.5¢ | $687.7K | 4.887M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 87494 | 14.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.0¢ | 2187900 | 13 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| PYC (ASX) Chart |